ISMP commends the U.S. Food and Drug Administration for requesting that Pfizer revise its current prescribing information and product packaging for vinCRIStine to eliminate syringe administration.
ISMP Newsroom
Safe medication practices depend on communication within the healthcare community, including patients and their families. ISMP is at the forefront of medication error reporting and guidance on safe medication practices, and is often cited in the media as a reputable resource for current information and emerging trends. In 2020, ISMP formally affiliated with ECRI to create one of the largest quality and safety entities in the world. ISMP's Newsroom includes ISMP and ECRI news releases, as well as ISMP blog posts, statements, and other communications.
To schedule an interview or request to be added to ISMP’s news release distribution lists, contact Renee Brehio.
Recent Updates
Practitioners should be prepared to take extra precautions with vials of neuromuscular blocking agents without the usual “Warning: Paralyzing Agent” statement required on vial caps and a propofol product that has double the concentration of what is available in the U.S.
ISMP special edition of the ISMP Medication Safety Alert!® acute care newsletter provides details on reports of emerging medication-related events and risks due to the COVID-19 pandemic. The special edition newsletters are being made available for free to the general public as well as subscribers.
ISMP special edition of the ISMP Medication Safety Alert!® acute care newsletter highlights the need to address the stress, anxiety, exhaustion, and depression healthcare workers are facing due to taxing workloads and the constant vigilance required to care for patients during COVID-19 crisis.
ISMP special edition of the acute care newsletter this week provides information on an error-prone dose expression on the label of an unapproved drug, ascorbic acid, that is being used to hasten recovery in COVID-19 patients; it also presents highlights from a Clinician Outreach and Communication Activity (COCA) webinar on the response of two health systems to the pandemic.
Special COVID-19 edition of the ISMP Medication Safety Alert!® acute care newsletter provides tips for safe and efficient use of automated dispensing cabinets (ADCs); and highlights the need for standardizing critical care drug infusions and reports on several recent errors with norepinephrine infusions administered to COVID-19 patients.
ISMP has issued its next special edition of the ISMP Medication Safety Alert!® acute care newsletter, which outlines possible strategies for handling upcoming shortages of smart infusion pumps and dedicated administration sets.
ISMP has developed an online resource page with links to vital COVID-19 safety-related information and tools.
Second special edition of the ISMP Medication Safety Alert!® acute care newsletter explores the use of extension sets to position infusion pumps outside COVID-19 patients’ rooms.
During the COVID-19 pandemic, ISMP is moving to special editions of the ISMP Medication Safety Alert! acute care newsletter that will focus only on information healthcare practitioners may find useful in their response efforts.
ISMP has been awarded a contract from the U.S. Food and Drug Administration to assess medication safety practices in the perioperative setting, from the time a patient is prepared for a procedure until he or she is discharged home.
New brand launch positions the nonprofit for new decade in healthcare.
Added Items Address Opioids, ADC Overrides
ISMP has published updated guidelines to help healthcare practitioners maximize the intended safety benefits of smart infusion pumps and better position their organizations for bi-directional interoperability with the electronic health record.
Reflecting on the 20-year anniversary of the watershed Institute of Medicine report To Err Is Human, ISMP has published a “top ten” list of the most persistent medication errors and safety issues covered in its newsletter in 2019.
ECRI Institute’s Partnership for Health IT Patient Safety releases whitepaper and guide for closing the loop on diagnostic testing and referrals.
As state legalization of medical marijuana sales spreads, issues have arisen with confusing product labeling that has led to errors.
ECRI Institute and the Institute for Safe Medication Practices (ISMP) announce the successful completion of their plans to join forces. Effective today, ISMP is an ECRI Institute affiliate. By joining together, the two patient safety leaders have created one of the largest healthcare quality and